Over 2,000 real rulings β analysed for what they mean to your team. Published every day.
Showing 1914 cases
PMCPA found Novo Nordisk breached Clauses 2, 5.1/9.1 and 28.1 over pharmacy-chain sponsorships that werenβt truly armβs length, free consumables seen as…
Complaint said a Rinvoq HCP webinar registration page gave dosing but omitted the SmPC grapefruit avoidance warning. Panel found the page wasnβt…
Complaint about a regional e-consent proposal and alleged proactive sharing of preprint data/off-label risk. Panel found the complainant provided limited evidence and…
Anonymous complaint alleged inadequate whistleblowing processes and potential off-label promotion via a Moderna US webcast. Panel found the complainant did not prove…
A Sanofi Global employeeβs LinkedIn job update included three product brand names and was liked/commented on by UK staff. Panel found the…
A US-only Apretude in-app advert was briefly visible to UK users after geo-restrictions failed. Panel initially found a Clause 5.1 breach, but…
Thirdβparty publisher email implied an unbiased ESMO update but linked to a page integrating Novartis Pluvicto promotion. UK HCPs saw EU SmPC/indication,…
Ex-employee alleged excessive alcohol/hospitality and inducement to prescribe at a conference, plus a poorly attended workshop becoming a βpseudo advisory boardβ. Panel…
Ex-employee complaint about Ontozry meetings. Panel found off-label promotion (incl PEG administration and monotherapy advocacy), references to EMA, and multiple certification/PI/AE statement…
A PCT pharmacist alleged a Teva-supported supplement about switching to CFC-free beclometasone inhalers was disguised promotion for Qvar. The Panel ruled Tevaβs…
Two websites promoted unlicensed N-carbamyl-L-glutamic acid and anhydrous betaine powders with therapeutic indications and dosing information. The Panel ruled this amounted to…
Anonymous complainants alleged inappropriate hospitality at a psychiatristsβ meeting sponsored by Bristol-Myers Squibb and Otsuka. The Panel found the meetingβs purpose was…
A nurse alleged misleading claims about Ferinject dosing and safety at a Syner-Med exhibition stand and in a detail aid. The Panel…
An anaesthetist complained that a Bayer Schering Pharma advert in The Economist promoted a prescription-only MS medicine to the public and raised…
A health professional received an unsolicited email about Gileadβs UK and Ireland Fellowship Programme and queried how his private address was obtained…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week β free.